Rafik BACHOUAL

Dr. Rafik BACHOUAL


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2007 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
RBRafik BACHOUAL
Rafik BACHOUAL
JBJorge Boczkowski
Jorge Boczkowski
DGDelphine Goven
Delphine Goven
NANadia Amara
Nadia Amara
LTLyes Tabet
Lyes Tabet
Sophie LanoneSophie Lanone
Sophie Lanone

1 July 2007 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Open access
PDF file
NANadia Amara
Nadia Amara
RBRafik BACHOUAL
Rafik BACHOUAL
MDMathieu Desmard
Mathieu Desmard
SGSlawomir Golda
Slawomir Golda
CGCecile Guichard
Cecile Guichard
JBJorge Boczkowski
Jorge Boczkowski
Chronic exposure to particulate air pollution is associated with lung function impairment. To determine the molecular mechanism(s) of this phenomenon, we investigated, in an alveolar human epithelial cell line (A549), whether diesel exhaust particles (DEPs), a main component of particulate air pollution, modulates the expression and activity of the matrix metalloprotease (MMP)-1, a collagenase involved in alveolar wall degradation. Interaction of DEPs with cigarette smoke, which also produces structural and functional lung alterations, was also investigated. A noncytotoxic concentration of DEPs induced an increase in MMP-1 mRNA and protein expression and activity in A549 cells without modifying the expression of the MMP inhibitors TIMP-1 and -2. This effect was not potentiated when cells were coexposed to noncytotoxic concentrations of cigarette smoke condensate. DEP-induced MMP-1 was associated with increased ERK 1/2 phosphorylation and upregulation of expression and activity of the NADPH oxidase analog NOX4. Cell transfection with a NOX4 small interfering RNA prevented these phenomena, showing the critical role of a NOX4 ERK 1/2 pathway in DEP-induced MMP-1 expression and activity. Similar results to those observed in A549 cells were obtained in another human lung epithelial cell line, NCI-H292. Furthermore, experiments in mice intratracheally instilled with DEPs confirmed the in vitro findings, showing the induction of NOX4 and MMP-1 protein expression in alveolar epithelial cells. We conclude that alveolar alterations secondary to MMP-1 induction could explain lung function impairment associated with exposure to particulate pollution.

1 September 2001 in Microbial Drug Resistance
Verified
Journal Article
Closed access
RBRafik BACHOUAL
Rafik BACHOUAL
SOS. Ouabdesselam
S. Ouabdesselam
FMF. Mory
F. Mory
CLC. Lascols
C. Lascols
CSC.-J. Soussy
C.-J. Soussy
JTJ. Tankovic
J. Tankovic
We looked for the presence of gyrA mutations in seven fluoroquinolone-resistant French clinical isolates of Campylobacter jejuni and Campylobacter coli . Three of the five isolates of C. jejuni and the two isolates of C. coli had high-level resistance to nalidixic acid (MICs 128-256 μ g/ml) and ciprofloxacin (MICs 32 μ g/ml). A gyrA mutation was found in all these isolates leading to the following substitutions: Thr86-Ile in four cases and Asp90-Tyr for one C. coli strain. One isolate had high-level resistance to nalidixic acid (MIC 64 μ g/ml) but low-level resistance to ciprofloxacin (MIC 2 μ g/ml) and also carried a gyrA mutation leading to a Thr86-Ala substitution. The last isolate of C. jejuni studied displayed an atypical resistance phenotype: It was resistant to high levels of ciprofloxacin (MIC 64 μ g/ml) but remained fully susceptible to nalidixic acid (MIC 2 μ g/ml). This phenotype was not explained by the presence of peculiar mutations in gyrA or gyrB . It carried a gyrA mutation leading to a Thr86-Ile substitution and was devoid of gyrB mutation. Despite numerous attempts with various degenerate oligonucleotide primers deduced from conserved regions of known parC genes, we were unable to amplify a corresponding sequence in C. jejuni or C. coli . First-step and second-step in vitro mutants, derived from reference strain C. coli ATCC 33559 with ciprofloxacin or moxifloxacin as selecting agents, were found to carry one and two mutations in gyrA , respectively. In contrast with the results obtained with clinical isolates, a variety of gyrA mutations were obtained in vitro .

1 June 2011 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
RBRafik BACHOUAL
Rafik BACHOUAL
WTWifak Talmoudi
Wifak Talmoudi
TBTarek Boussetta
Tarek Boussetta
FBFrançoise Braut
Françoise Braut
JEJamel El-Benna
Jamel El-Benna

1 February 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
ABAmir Bouallegue
Amir Bouallegue
ACAngela Casillo
Angela Casillo
FCFatma Chaari
Fatma Chaari
AGAnnalisa La Gatta
Annalisa La Gatta
RLRosa Lanzetta
Rosa Lanzetta
SESemia Ellouz-Chaabouni
Semia Ellouz-Chaabouni

28 January 2010 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
YKYolande Kroviarski
Yolande Kroviarski
MDMaya Debbabi
Maya Debbabi
RBRafik BACHOUAL
Rafik BACHOUAL
APAxel Pe´rIanin
Axel Pe´rIanin
MGMarie‐Anne Gougerot‐Pocidalo
Marie‐Anne Gougerot‐Pocidalo
PDPham My‐Chan Dang
Pham My‐Chan Dang
NADPH oxidase activator 1 (NOXA1) together with NADPH oxidase organizer 1 (NOXO1) are key regulatory subunits of the NADPH oxidase NOX1. NOX1 is expressed mainly in colon epithelial cells and could be involved in mucosal innate immunity by producing reactive oxygen species (ROS). Contrary to its phagocyte counterpart NOX2, the mechanisms involved in NOX1 activation and regulation remain unclear. Here we report that NOX1 activity is regulated through MAP kinase (MAPK), protein kinase C (PKC), and protein kinase A (PKA)‐dependent phosphorylation of NOXA1. We identified Ser‐282 as target of MAPK and Ser‐172 as target of PKC and PKA in vitro and in a transfected human embryonic kidney 293 (HEK293) cell model using site directed mutagenesis and phosphopeptide mapping analysis. In HEK293 cells, phosphorylation of these sites occurred at a basal level and down‐regulated constitutive NOX1 activity. Indeed, S172A and S282A single mutants of NOXA1 significantly up‐regulated constitutive NOX1‐derived ROS production, and S172A/S282A double mutant further increased it, as compared to wild‐type NOXA1. Furthermore, phosphorylation of NOXA1 on Ser‐282 and Ser‐172 decreased its binding to NOX1 and Rac1. These results demonstrated a critical role of NOXA1 phosphorylation on Ser‐282 and Ser‐172 in preventing NOX1 hyperactivation through the decrease of NOXA1 interaction to NOX1 and Rac1.— Kroviarski, Y., Debbabi, M., Bachoual, R., Pe´rianin, A, Gougerot‐Pocidalo, M.‐A, El‐Benna, J., Dang, P. M. Phosphorylation of NADPH oxidase activator 1 (NOXA1) on serine 282 by MAP kinases and on serine 172 by protein kinase C and protein kinase A prevents NOX1 hyperactivation. FASEB J . 24, 2077–2092 (2010). www.fasebj.org